19 results
8-K
EX-99.1
HUMA
Humacyte Inc
29 Feb 24
Other Events
4:02pm
vein harvest in diabetics, women, and the overweight Durable and highly uniform in diameter and quality Potentially Transforming CABG Care: Greater … % develop infection 23% have persistent swelling; worse in obese and diabetic patients; 2x worse in women SVGs do not last long enough: ~33% of patients
DEF 14A
HUMA
Humacyte Inc
29 Apr 22
Definitive proxy
6:41am
, Inc., a public late-stage biopharmaceutical company. She is the Chair of the National Board of Directors of the Association for Women in Science
424B7
ls0hsx90v7rjeywk3rx
4 Apr 22
Prospectus with selling stockholder info
5:22pm
POS AM
u1chjj
30 Mar 22
Prospectus update (post-effective amendment)
5:07pm
8-K
EX-99.1
itgf2t
10 Jan 22
Regulation FD Disclosure
4:05pm
424B7
633ffp8b gq2b8pno
10 Dec 21
Prospectus with selling stockholder info
12:00am
POS AM
v1pbuho3c6nunpsian
19 Nov 21
Prospectus update (post-effective amendment)
5:26pm
424B7
0kuu28m
27 Oct 21
Prospectus with selling stockholder info
2:42pm
8-K
EX-99.3
m5j67ll4x0
27 Aug 21
Report of Independent Registered Public Accounting Firm
9:01pm
8-K
EX-99.2
9ugz ai13jwpl1a4x
7 Jun 21
Humacyte to Provide Investor Update on June 7
5:29pm
425
EX-99.2
scef axbh
7 Jun 21
Business combination disclosure
5:27pm
8-K
EX-99.2
mif5a
17 Feb 21
Entry into a Material Definitive Agreement
8:45am
425
EX-99.2
4a3 m4u26nyilfd5
17 Feb 21
Business combination disclosure
8:43am
- Prev
- 1
- Next